There are reasons why top VCs are taking these bets, even if it’s a long road to commercial outcomes for deep tech innovation in healthcare. An important reason is the deep tech background of founders from the Indian diaspora.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment